DGAP-News: Mensch und Maschine Software SE / Key word(s): Quarter Results Mensch und Maschine Software SE discloses Q1 report 22.04.2015 / 08:26 --------------------------------------------------------------------- Sparkling start to year well above expectations - Sales +13.5% / Net profit +47% / Cash flows +151% Wessling, April 22, 2015 - Sparkling start to the year in Q1/2015 for Mensch und Maschine Software SE (MUM - ISIN DE0006580806), a CAD/CAM specialist company: Sales and gross margin had double digit increases, while the purely operating EBITDA grew by more than EUR 1.4 mln or 57%, well above expectations. Sales amounted to EUR 42.80 mln (PY: 37.72 / +13.5%), with M+M Software contributing EUR 10.34 mln (PY: 9.84 / +5.1%) and the VAR Business contributing EUR 32.45 mln (PY: 27.88 / +16%). Nearly one third of the VAR Business growth was due to the Swiss Franc increase against the Euro, the remainder - still double digit - was purely organic. Gross margin climbed disproportionately to EUR 21.92 mln (PY: 18.99 / +15.4%), with contributions of EUR 9.88 mln (PY: 9.22 / +7.2%) from Software and EUR 12.04 mln (PY: 9.78 / +23%) from VAR Business - also here, just over two third of the growth was purely organic. Operating profit EBITDA before depreciation, amortization, interest and taxes climbed to EUR 2.45 mln (PY: 2.13 / +15%) for Software and EUR 1.40 mln (PY: 1.07 / +31%) for the VAR Business. Group EBITDA came in at EUR 3.85 mln (PY: 3.20 / +21%). After deducting EUR 0.75 mln contribution from the sale of the Distribution business, closed 2011, in the previous year, group EBITDA on a purely operating basis increased by EUR 1.4 mln or a remarkable 57%. In the VAR segment, the purely operating EBITDA was more than quadrupled - from previous year's EUR 0.32 mln to EUR 1.40 mln. Net profit after minority shares increased to EUR 1.57 mln (PY: 1.07 / +47%), or 10 Cents (PY: 7) per share. The net profit calculation is based on an expected 30% tax rate for 2015, while the previous year was restated to the actual 26.3% annual tax rate. Operating cash flows more than doubled to EUR 6.67 mln (PY: 2.66 / +151%). After the good start, M+M CEO Adi Drotleff is optimistic: 'The higher than expected business development in Q1 makes us confident that the targets for fiscal year 2015 are achievable: Sales should clearly exceed EUR 150 mln (PY: 140), for EBITDA a target range from EUR 11 to 12 mln (PY: 10.87 / purely operating 7.87) was defined, net profit / EPS are expected to be in the same range as in the previous year (EUR 3.72 min / 24 Cents) - plus/minus a certain volatility, mainly depending on EBITDA, currency exchange effects on the financial result and the actual tax rate.' --------------------------------------------------------------------- 22.04.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Mensch und Maschine Software SE Argelsrieder Feld 5 82234 Wessling Germany Phone: +49 (0)815 3933-0 Fax: +49 (0)815 3933-100 E-mail: investor-relations@mum.de Internet: www.mum.de ISIN: DE0006580806 WKN: 658 080 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich (m:access), Stuttgart; Open Market (Entry Standard) in Frankfurt End of News DGAP News-Service --------------------------------------------------------------------- 346923 22.04.2015
DGAP-News: Mensch und Maschine Software SE discloses Q1
Top 10 Most Recent News Articles
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage
The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...
Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact
A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....
Continue Reading
SahajMobile's $25M Boost: Impact on Bangladesh Market
Untapped Digital Frontier in Bangladesh There's an undeniable buzz around SahajMobile's recent $25 million credit facility, and it's one worth dissecting. This shot of capital, lined up with ALMA as part of SahajMobile’s Series A gamble, is setting the stage for a real shuffle in Bangladesh's digital landscape. Plugging into a Market Gap Ever since it hit the ground...
Continue Reading
Rock Tech Uncovers Major Lithium Discovery at Victory
Rock Tech's Game-Changer at Victory Folks, we've got a shake-up in the lithium landscape over in Ontario, courtesy of Rock Tech Lithium Inc. They just unearthed something quite promising at their Victory Project: a spanking new spodumene-bearing pegmatite discovery. Now I know, if you're like me, you're thinking, 'What's the angle here?' Well, this isn't just another hole...
Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull
Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...
Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?
A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...
Continue ReadingPeptide Tracker Refresh Unveils New Planning Features
Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...
Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again
Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...
Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion
TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...
Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage
Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...
Continue ReadingTop 5 Most Recently Viewed Articles
Exciting Line-Up of Athletes for Future Games in Abu Dhabi
Global Stars Confirmed for Games of the Future 2025 Some of the biggest names in phygital sports and esports from around the world will head to Abu Dhabi for the ultimate showdown in next-gen sports from 18-23 December. Phygital International, the UAE-based promoter of phygital sports globally, has just confirmed the lineup for the Games of the Future Abu Dhabi 2025 (GOTF...
Continue Reading
Rhythm Pharmaceuticals Earnings Report: What to Watch For
Eyes on Rhythm Pharmaceuticals: Earnings Just Around the Corner A steady hum of anticipation is in the air as Rhythm Pharmaceuticals (NASDAQ:RYTM) gears up to unveil its quarterly earnings on February 26, 2026. While investors hung onto the last report’s fallout, expectations this time are swirling around whether RYTM can turn things around after a slip last quarter....
Continue Reading
First Capital REIT Reports Impressive Q3 2024 Growth Metrics
First Capital REIT's Strong Q3 Results Highlight Robust Performance First Capital Real Estate Investment Trust (TSX: FCR) has announced remarkable financial results for the third quarter ending September 30, indicating robust operational performance backed by strong leasing activities. The detailed report is made accessible to investors on the Trust's official website....
Continue Reading
Sherwin-Williams Faces Challenges After Lowering Earnings Outlook
Sherwin-Williams Adjusts Earnings Projections Following Q2 Results The Sherwin-Williams Company (NYSE: SHW) recently faced some challenges after reporting lower-than-expected second-quarter earnings. With adjusted earnings per share (EPS) of $3.38, the results fell short of Wall Street's predictions, which had estimated $3.81 per share. The company's quarterly revenue,...
Continue Reading
Oculis Financial Results & Clinical Update for Q2 2024
Oculis Reports Q2 Financial Results and Company Update Oculis Holding AG (NASDAQ: OCS; XICE: OCS), a global biopharmaceutical company focused on improving eye care, has shared its latest financial results and significant developments. The highlights from the second quarter ending June 30, 2024, illustrate the company's dedication to advancing its innovative clinical...
Continue Reading